MCID: PYR010
MIFTS: 53

Peyronie's Disease malady

Categories: Rare diseases, Reproductive diseases

Aliases & Classifications for Peyronie's Disease

About this section
Sources:
11Disease Ontology, 13DISEASES, 29ICD10, 31ICD9CM, 35MalaCards, 38MeSH, 44NCIt, 47NIH Rare Diseases, 49Novoseek, 61SNOMED-CT, 67UMLS
See all MalaCards sources

Aliases & Descriptions for Peyronie's Disease:

Name: Peyronie's Disease 35 11 13
Peyronie Disease 11 47 49 67
Balanitis Xerotica Obliterans 67
Induratio Penis Plastica 11
 
Peyronie's Fibromatosis 11
Penile Induration 38
Peyronies Disease 35
Penile Curvature 47

Classifications:



External Ids:

Disease Ontology11 DOID:8616
ICD1029 N48.6
ICD9CM31 607.85
MeSH38 D010411
NCIt44 C3316

Summaries for Peyronie's Disease

About this section
Wikipedia:70 Peyronie\'s disease or Peyronie disease (/peɪroʊˈniː/), also known as induratio penis plastica (IPP)... more...

MalaCards based summary: Peyronie's Disease, also known as peyronie disease, is related to dupuytren contracture dupuytren contracture 1, included and keratopathy, and has symptoms including abnormality of the genitourinary system, abnormality of the skeletal system and edema of penis. An important gene associated with Peyronie's Disease is IFNA2 (Interferon Alpha 2), and among its related pathways are NO-dependent CFTR activation (normal and CF) and Glypican 1 network. Affiliated tissues include small intestine, bone and prostate, and related mouse phenotypes are renal/urinary system and respiratory system.

Related Diseases for Peyronie's Disease

About this section

Diseases related to Peyronie's Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 33)
idRelated DiseaseScoreTop Affiliating Genes
1dupuytren contracture dupuytren contracture 1, included10.8
2keratopathy10.3SMAD3, TGFB1
3diamond-blackfan anemia10.3TGFB1, TGFB2
4acromicric dysplasia10.3TGFB1, TGFB2
5fibrosclerosis of breast10.2TGFB1, TGFB2
6hypospadias10.2
7tgfbr1-related loeys-dietz syndrome10.2TGFB2, TGFB3
8peanut allergy10.2TGFB1, TGFB2
9loeys-dietz syndrome 410.2TGFB2, TGFB3
10vitreous abscess10.2TGFB1, TGFB2
11renal clear cell carcinoma10.2TGFB2, TGFB3
12leukemia10.1TGFB1, TGFB2
13naegeli-franceschetti-jadassohn syndrome/dermatopathia pigmentosa reticularis10.1DCN, TGFB1
14strawberry gallbladder10.0TGFB1, TGFB2, TGFB3
15serous labyrinthitis10.0PDE5A, TGFB1
16idiopathic corneal edema10.0TGFB1, TGFB2, TGFB3
17brucella canis brucellosis10.0SMAD3, TGFB2
1846 xy gonadal dysgenesis10.0TGFB1, TGFB2, TGFB3
19actinomycosis10.0DCN, SMAD3, TGFB1
20adenosine monophosphate deaminase deficiency erythrocyte type10.0SMAD3, TGFB2, TGFB3
21loin pain hematuria syndrome9.9SMAD7, TGFB1
22west syndrome9.8DCN, TGFB2
23pulmonary edema9.8
24priapism9.8
25beare-stevenson cutis gyrata syndrome9.7DCN, TGFB1
26head and neck carcinoma9.7IFNA2, PDE5A, SMAD3, TGFB1
27benign neonatal seizures9.7SMAD3, SMAD7, TGFB1
28epidemic typhus9.7SMAD3, TGFB1, TGFB2, TGFB3
29benign struma ovarii9.7SMAD3, SMAD7, TGFB1
30acromesomelic dysplasia9.6SMAD3, SMAD7, TGFB3
31nephropathy familial with hyperuricemia9.3DCN, SMAD3, SMAD7, TGFB1
32colorectal cancer8.3IFNA2, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
33twin-to-twin transfusion syndrome7.7ACTG2, DCN, IFNA2, SMAD3, SMAD7, TGFB1

Comorbidity relations with Peyronie's Disease via Phenotypic Disease Network (PDN):


Prostatic HypertrophyBladder Neck Obstruction
Urethral Stricture

Graphical network of the top 20 diseases related to Peyronie's Disease:



Diseases related to peyronie's disease

Symptoms for Peyronie's Disease

About this section

Human phenotypes related to Peyronie's Disease:

 63
id Description HPO Frequency HPO Source Accession
1 abnormality of the genitourinary system63 HP:0000119
2 abnormality of the skeletal system63 HP:0000924

UMLS symptoms related to Peyronie's Disease:


edema of penis, discharge from penis, pain in penis, penile swelling, penile burning sensation

Drugs & Therapeutics for Peyronie's Disease

About this section

Drugs for Peyronie's Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 49)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SevelamerapprovedPhase 37452757-95-6, 152751-57-03085017
Synonyms:
Sevelamer
 
Sevelamero
Sevelamerum
Sévélamer
2Chelating AgentsPhase 31365
3
AcetylcholineapprovedPhase 277651-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
4
Lidocaineapproved, vet_approvedPhase 21226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
5onabotulinumtoxinAPhase 2626
6Peripheral Nervous System AgentsPhase 222776
7Pharmaceutical SolutionsPhase 27793
8Neurotransmitter AgentsPhase 217734
9incobotulinumtoxinAPhase 2635
10Botulinum ToxinsPhase 2669
11abobotulinumtoxinAPhase 2626
12Neuromuscular AgentsPhase 21129
13Botulinum Toxins, Type APhase 2630
14Cholinergic AgentsPhase 23846
15Diuretics, Potassium SparingPhase 21827
16Sodium Channel BlockersPhase 21515
17Central Nervous System DepressantsPhase 212806
18Anesthetics, LocalPhase 23272
19AnestheticsPhase 29001
20Anti-Arrhythmia AgentsPhase 22969
21
MethyltestosteroneapprovedPhase 154658-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
 
17beta-Hydroxy-17-methylandrost-4-en-3-one
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Virilon
22
Testosteroneapproved, investigationalPhase 154658-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
 
Intrinsa
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Hydrate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
23
Vitamin Eapproved, nutraceutical, vet_approvedPhase 140659-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'R)-α-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
5,7,8-trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
24
Ergocalciferolapproved, nutraceuticalPhase 1123250-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
25Testosterone 17 beta-cypionatePhase 1546
26Testosterone undecanoatePhase 1546
27
Testosterone enanthatePhase 1546315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
28TocotrienolsPhase 1402
29VitaminsPhase 15095
30vitamin dPhase 11653
31Trace ElementsPhase 15802
32Protective AgentsPhase 17190
33TocopherolsPhase 1406
34Bone Density Conservation AgentsPhase 13266
35AndrogensPhase 11275
36MicronutrientsPhase 15802
37AntioxidantsPhase 12928
38Antineoplastic Agents, HormonalPhase 15407
39ErgocalciferolsPhase 11232
40Anabolic AgentsPhase 1499
41Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 112767
42HormonesPhase 113979
43Hormone AntagonistsPhase 112778
44Vitamin D2NutraceuticalPhase 11232
45CalciferolNutraceuticalPhase 11334
46TocotrienolNutraceuticalPhase 1402
47TocopherolNutraceuticalPhase 1406
48Phosphodiesterase 5 Inhibitors571
49Mitogens1526

Interventional clinical trials:

(show all 20)
idNameStatusNCT IDPhase
1Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies DiseaseActive, not recruitingNCT02298829Phase 4
2A Study of AA4500 in Men With Peyronie's DiseaseCompletedNCT01243411Phase 3
3A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's DiseaseCompletedNCT01685437Phase 3
4Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221597Phase 3
5Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221623Phase 3
6An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's DiseaseCompletedNCT02267460Phase 3
7A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on DialysisTerminatedNCT00833768Phase 3
8Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)Unknown statusNCT01184586Phase 2
9The Safety and Effectiveness of AA4500 in Subjects With Peyronie's DiseaseCompletedNCT00755222Phase 2
10Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's DiseaseCompletedNCT01430169Phase 2
11H-22411: BOTOX® for Peyronie's DiseaseRecruitingNCT00812838Phase 2
12Clostridium Histolyticum Collagenase Injection for Urethral DiseaseNot yet recruitingNCT02948842Phase 2
13Peyronie's Disease Treatment ProtocolCompletedNCT02072018Phase 1
14Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PDCompletedNCT02395029Phase 1
15Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's DiseaseActive, not recruitingNCT01578473Phase 1
16Efficacy of Extracorporal Shock Wave Therapy in Patient With Chronic Non-bacterial Prostatitis / Chronic Pelvic Pain SyndromeUnknown statusNCT01714830
17Change in Penile Length Following Bilateral Nerve-Sparing Radical ProstatectomyCompletedNCT00800813
18Management of Peyronie's Disease With Adipose Tissue Stem CellRecruitingNCT02414308
19Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary ConditionsRecruitingNCT01953523
20Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014RecruitingNCT01503034

Search NIH Clinical Center for Peyronie's Disease


Cochrane evidence based reviews: penile induration

Genetic Tests for Peyronie's Disease

About this section

Anatomical Context for Peyronie's Disease

About this section

MalaCards organs/tissues related to Peyronie's Disease:

35
Small intestine, Bone, Prostate, Kidney, Endothelial, Testes, Monocytes

Animal Models for Peyronie's Disease or affiliated genes

About this section

MGI Mouse Phenotypes related to Peyronie's Disease:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053679.1DCN, NOS2, SMAD3, TGFB1, TGFB2
2MP:00053889.0DCN, NOS2, TGFB1, TGFB2, TGFB3
3MP:00053699.0DCN, NOS2, SMAD7, TGFB1, TGFB2
4MP:00053798.6DCN, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
5MP:00053908.6DCN, NOS2, SMAD3, TGFB1, TGFB2, TGFB3
6MP:00053898.6DCN, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
7MP:00053848.2DCN, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
8MP:00053828.1DCN, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
9MP:00053818.1DCN, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
10MP:00053917.8DCN, NOS2, SMAD3, TGFB1, TGFB2, TGFB3

Publications for Peyronie's Disease

About this section

Articles related to Peyronie's Disease:

(show top 50)    (show all 624)
idTitleAuthorsYear
1
Role of extracorporeal shock wave therapy in management of Peyronie's disease: A preliminary report. (28057983)
2016
2
A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study. (24893912)
2016
3
Collagenase Clostridium Histolyticum for the Treatment of Peyronie's Disease: A 'Real World' Clinical Perspective. (27770352)
2016
4
The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease. (25804087)
2015
5
Intralesional Interferon-I+2b Improves Penile Curvature in Peyronie's Disease. (26386274)
2015
6
Commentary On: Peyronie's Disease and Autoimmunity-A Real-Life Clinical Study and Comprehensive Review. (25736299)
2015
7
Psychosexual Symptoms and Treatment of Peyronie's Disease Within a Collaborative Care Model. (25548648)
2014
8
Peyronie's disease: review and recent advances. (24984940)
2014
9
Silencing histone deacetylase 2 using small hairpin RNA induces regression of fibrotic plaque in a rat model of Peyronie's disease. (24841412)
2014
10
Baseline Characteristics from an Ongoing Phase 3 Study of Collagenase Clostridium Histolyticum in Patients with Peyronie's Disease. (24112401)
2013
11
Penile corporoplasty with Yachia's technique for Peyronie's disease: Single center experience with 117 patients. (24049379)
2013
12
Surgery for Peyronie's disease. (23178395)
2013
13
The clinical and psychosocial impact of Peyronie's disease. (23544796)
2013
14
Re: long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study. (22325532)
2012
15
A new, innovative, lengthening surgical procedure for Peyronie's disease by penile prosthesis implantation with double dorsal-ventral patch graft: the "sliding technique". (22429331)
2012
16
Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study. (22176734)
2012
17
Comparison between AMS 700a8c CX and Coloplasta8c Titan Inflatable Penile Prosthesis for Peyronie's Disease Treatment and Remodeling: Clinical Outcomes and Patient Satisfaction. (23210973)
2012
18
Re: The Role of Vacuum Pump Therapy to Mechanically Straighten the Penis in Peyronie's Disease. (22088643)
2011
19
Risk factors of Peyronie's disease. What does our clinical experience show? (20955309)
2011
20
Current surgical management of severe peyronie's disease. (21098900)
2010
21
Predicting delay in presentation in men with Peyronie's disease. (20929519)
2010
22
The combination of vein grafting and two different types of corporeal plication in complex curvature due to Peyronie's disease. (20389155)
2010
23
Medical management of Peyronie's disease. (18974422)
2009
24
Risk factors for emotional and relationship problems in Peyronie's disease. (18638001)
2008
25
Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. (17706714)
2007
26
The natural history of Peyronie's disease. (17601314)
2007
27
The use of collagenase in the treatment of Peyronie's disease M.K. Gelbard, A. Lindner, and J.J. Kaufman. (17727345)
2007
28
Surgical therapy of Peyronie's disease. (18219716)
2006
29
Evaluation of post-operative residual function of corpora cavernosa after soft penile prosthesis implant for Peyronie's disease. (16929602)
2006
30
A critical analysis of nonsurgical treatment of Peyronie's disease. (16698449)
2006
31
The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease. (15839925)
2005
32
A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction: functional and satisfaction outcomes. (16422916)
2005
33
Conservative management options for Peyronie's disease. (16238920)
2005
34
Alpha-1-antitrypsin levels and genetic variation of the alpha-1-antitrypsin gene in Peyronie's disease. (15474273)
2004
35
Corporoplasty with saphenous venous patch graft for Peyronie's disease. (15636031)
2004
36
Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach. (14665898)
2004
37
Patient and partner satisfaction and long-term results after surgical treatment for Peyronie's disease. (12837432)
2003
38
Peyronie's disease. Who is at risk? (12518211)
2002
39
Intralesional interferon-alpha-2b for the treatment of Peyronie's disease. (12454683)
2002
40
Management of Peyronie's disease--a review. (11550782)
2001
41
Peyronie's disease. (11402589)
2001
42
Current sexual functioning in 106 patients with Peyronie's disease treated with radiotherapy 9 years earlier. (11113753)
2000
43
The use of betamethasone and hyaluronidase injections in the treatment of Peyronie's disease. (11195899)
2000
44
Microsatellite alterations and loss of heterozygosity in Peyronie's disease. (10953165)
2000
45
Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease. (10799165)
2000
46
Saphenous vein harvesting by 'stripping' technique and 'W'-shaped patch covering after plaque incision in treatment of Peyronie's disease. (11416831)
2000
47
Intralesional recombinant interferon alpha-2b in Peyronie's disease. (11037665)
2000
48
Peyronie's disease: current management. (10465229)
1999
49
Vein grafting of tunical incisions in the treatment of Peyronie's disease. (10349258)
1998
50
La Peyronie's disease. Our experience]. (2186297)
1990

Variations for Peyronie's Disease

About this section

Expression for genes affiliated with Peyronie's Disease

About this section
Search GEO for disease gene expression data for Peyronie's Disease.

Pathways for genes affiliated with Peyronie's Disease

About this section

Pathways related to Peyronie's Disease according to GeneCards Suite gene sharing:

(show all 46)
idSuper pathwaysScoreTop Affiliating Genes
19.7NOS2, PDE5A
29.7TGFB1, TGFB3
3
Show member pathways
9.3SMAD3, SMAD7, TGFB1
49.3SMAD3, SMAD7, TGFB1
59.3SMAD3, SMAD7, TGFB1
6
Show member pathways
9.3SMAD3, SMAD7, TGFB1
7
Show member pathways
9.2SMAD7, TGFB1, TGFB3
8
Show member pathways
9.2SMAD3, TGFB1, TGFB2
9
Show member pathways
9.2SMAD3, TGFB1, TGFB2
109.1TGFB1, TGFB2, TGFB3
119.1TGFB1, TGFB2, TGFB3
12
Show member pathways
9.1TGFB1, TGFB2, TGFB3
139.1TGFB1, TGFB2, TGFB3
14
Show member pathways
9.1TGFB1, TGFB2, TGFB3
159.1TGFB1, TGFB2, TGFB3
16
Show member pathways
9.1TGFB1, TGFB2, TGFB3
179.1TGFB1, TGFB2, TGFB3
188.8SMAD3, SMAD7, TGFB1, TGFB3
19
Show member pathways
8.7NOS2, TGFB1, TGFB2, TGFB3
208.7NOS2, TGFB1, TGFB2, TGFB3
218.7NOS2, TGFB1, TGFB2, TGFB3
22
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
238.7SMAD3, TGFB1, TGFB2, TGFB3
24
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
25
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
268.7SMAD3, TGFB1, TGFB2, TGFB3
27
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
28
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
298.7SMAD3, TGFB1, TGFB2, TGFB3
308.7SMAD3, TGFB1, TGFB2, TGFB3
31
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
32
Show member pathways
8.6DCN, TGFB1, TGFB2, TGFB3
338.6DCN, TGFB1, TGFB2, TGFB3
348.6DCN, TGFB1, TGFB2, TGFB3
358.4IFNA2, NOS2, TGFB1, TGFB2, TGFB3
36
Show member pathways
8.4IFNA2, SMAD3, TGFB1, TGFB2, TGFB3
378.4NOS2, SMAD3, TGFB1, TGFB2, TGFB3
388.4NOS2, SMAD3, TGFB1, TGFB2, TGFB3
398.2SMAD3, SMAD7, TGFB1, TGFB2, TGFB3
40
Show member pathways
8.2SMAD3, SMAD7, TGFB1, TGFB2, TGFB3
418.2SMAD3, SMAD7, TGFB1, TGFB2, TGFB3
428.2SMAD3, SMAD7, TGFB1, TGFB2, TGFB3
43
Show member pathways
8.1IFNA2, NOS2, SMAD3, TGFB1, TGFB2, TGFB3
44
Show member pathways
8.1IFNA2, NOS2, SMAD3, TGFB1, TGFB2, TGFB3
45
Show member pathways
7.9ACTG2, NOS2, TGFB1, TGFB2, TGFB3
467.9ACTG2, SMAD3, TGFB1, TGFB2, TGFB3

GO Terms for genes affiliated with Peyronie's Disease

About this section

Cellular components related to Peyronie's Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:00310939.6TGFB1, TGFB2, TGFB3
2extracellular matrixGO:00310128.6DCN, TGFB1, TGFB2, TGFB3
3extracellular spaceGO:00056157.4ACTG2, DCN, IFNA2, TGFB1, TGFB2, TGFB3

Biological processes related to Peyronie's Disease according to GeneCards Suite gene sharing:

(show all 50)
idNameGO IDScoreTop Affiliating Genes
1regulation of bindingGO:005109810.5SMAD3, TGFB1
2positive regulation of extracellular matrix assemblyGO:190120310.5SMAD3, TGFB1
3evasion or tolerance of host defenses by virusGO:001904910.5SMAD3, TGFB1
4SMAD protein complex assemblyGO:000718310.5SMAD3, TGFB1
5frontal suture morphogenesisGO:006036410.4TGFB1, TGFB3
6regulation of epithelial to mesenchymal transition involved in endocardial cushion formationGO:190500510.4TGFB1, TGFB3
7regulation of striated muscle tissue developmentGO:001620210.4SMAD3, TGFB1
8lens fiber cell differentiationGO:007030610.4SMAD3, TGFB1
9negative regulation of DNA replicationGO:000815610.3TGFB1, TGFB3
10positive regulation of collagen biosynthetic processGO:003296710.3TGFB1, TGFB3
11ossification involved in bone remodelingGO:004393210.3TGFB1, TGFB3
12endoderm developmentGO:000749210.2SMAD3, TGFB1
13positive regulation of SMAD protein import into nucleusGO:006039110.2TGFB1, TGFB3
14negative regulation of mitotic cell cycleGO:004593010.2SMAD3, TGFB1
15mammary gland developmentGO:003087910.2TGFB1, TGFB3
16regulation of transforming growth factor beta2 productionGO:003290910.2SMAD3, TGFB2
17positive regulation of protein localization to nucleusGO:190018210.1TGFB1, TGFB2
18uterine wall breakdownGO:004270410.1TGFB2, TGFB3
19negative regulation of immune responseGO:005077710.1TGFB1, TGFB2
20positive regulation of bone mineralizationGO:003050110.0SMAD3, TGFB1, TGFB3
21ventricular septum morphogenesisGO:00604129.9SMAD7, TGFB2
22response to laminar fluid shear stressGO:00346169.9SMAD7, TGFB1, TGFB3
23extrinsic apoptotic signaling pathwayGO:00971919.8SMAD3, TGFB1, TGFB2
24SMAD protein import into nucleusGO:00071849.8TGFB1, TGFB2, TGFB3
25salivary gland morphogenesisGO:00074359.7TGFB1, TGFB2, TGFB3
26ureteric bud developmentGO:00016579.7SMAD3, SMAD7, TGFB1
27regulation of transforming growth factor beta receptor signaling pathwayGO:00170159.7SMAD3, SMAD7, TGFB1
28response to progesteroneGO:00325709.7TGFB1, TGFB2, TGFB3
29pathway-restricted SMAD protein phosphorylationGO:00603899.7SMAD7, TGFB1, TGFB2
30positive regulation of cell divisionGO:00517819.7TGFB1, TGFB2, TGFB3
31negative regulation of macrophage cytokine productionGO:00109369.6TGFB1, TGFB2, TGFB3
32platelet degranulationGO:00025769.6TGFB1, TGFB2, TGFB3
33positive regulation of pathway-restricted SMAD protein phosphorylationGO:00108629.6TGFB1, TGFB2, TGFB3
34cell cycle arrestGO:00070509.6SMAD3, TGFB1, TGFB2
35cell growthGO:00160499.5TGFB1, TGFB2, TGFB3
36face morphogenesisGO:00603259.5TGFB1, TGFB2, TGFB3
37positive regulation of protein secretionGO:00507149.4TGFB1, TGFB2, TGFB3
38negative regulation of cell growthGO:00303089.4SMAD3, TGFB1, TGFB2
39positive regulation of transcription, DNA-templatedGO:00458939.4IFNA2, SMAD3, TGFB1, TGFB3
40SMAD protein signal transductionGO:00603959.3SMAD3, TGFB1, TGFB2, TGFB3
41cell-cell junction organizationGO:00452169.3SMAD3, TGFB1, TGFB2, TGFB3
42positive regulation of epithelial to mesenchymal transitionGO:00107189.2SMAD3, TGFB1, TGFB2, TGFB3
43negative regulation of gene expressionGO:00106299.2IFNA2, NOS2, TGFB1, TGFB2
44negative regulation of transforming growth factor beta receptor signaling pathwayGO:00305129.1SMAD3, SMAD7, TGFB1, TGFB3
45transforming growth factor beta receptor signaling pathwayGO:00071798.7SMAD3, SMAD7, TGFB1, TGFB2, TGFB3
46negative regulation of cell proliferationGO:00082858.7SMAD3, TGFB1, TGFB2, TGFB3
47positive regulation of gene expressionGO:00106288.4ACTG2, SMAD3, TGFB1, TGFB2
48wound healingGO:00420608.4DCN, SMAD3, TGFB1, TGFB2, TGFB3
49positive regulation of transcription from RNA polymerase II promoterGO:00459448.3DCN, SMAD3, SMAD7, TGFB1, TGFB3
50response to hypoxiaGO:00016668.1NOS2, SMAD3, TGFB1, TGFB2, TGFB3

Molecular functions related to Peyronie's Disease according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1type I transforming growth factor beta receptor bindingGO:00347139.8SMAD7, TGFB1, TGFB3
2transforming growth factor beta receptor bindingGO:00051609.7SMAD3, TGFB1, TGFB2
3type III transforming growth factor beta receptor bindingGO:00347149.7TGFB1, TGFB2, TGFB3
4type II transforming growth factor beta receptor bindingGO:00051149.7TGFB1, TGFB2, TGFB3
5growth factor activityGO:00080839.3TGFB1, TGFB2, TGFB3
6collagen bindingGO:00055189.3DCN, SMAD3, SMAD7
7cytokine activityGO:00051259.1IFNA2, TGFB1, TGFB2, TGFB3
8protein heterodimerization activityGO:00469828.7SMAD3, TGFB1, TGFB2, TGFB3

Sources for Peyronie's Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet